Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Enfusion Narrows FY2024 Sales Guidance from $200.00M-210.00M to $202.00M-205.00M VS Est. 204.8M

Author: Benzinga Newsdesk | November 04, 2024 07:40am

Enfusion (NYSE:ENFN) narrows FY2024 sales outlook from $200.00 million-210.00 million to $202.00 million-205.00 million.

Posted In: ENFN